Condition: Ventral Hernia · Sponsor: AbbVie
A ventral hernia happens when the muscles in the front of your belly become weak and let organs push through, causing a bulge. If it gets worse, intestines can slip into the bulge, leading to serious pain and health problems. This study aims to asses if AGN-151607-DP is safe and effective for closing the belly wall after open ventral hernia surgery, without needing a complex procedure. Adverse Events and change in disease activity will be assessed. AGN-151607-DP is an investigational drug being developed to treat ventral hernia. Participants will be randomly placed in treatment groups to receive either AGN151607-DP or matching placebo. Approximately 200 adult participants with midline ventral hernia needing open surgical repair will be enrolled in approximately 30 sites in the United States. Participants will receive intramuscular injections of AGN-161607-DP or matching placebo on Day 1. Duration of the study is approximately 25 months. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular weekly visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
This description comes directly from the study's public registry record.
ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com
Always discuss trial participation with your own doctor first.
| CARI Clinical Trials INC /ID# 278844 | Riverside, California, United States | Recruiting |
| University of Florida - Jacksonville /ID# 261992 | Jacksonville, Florida, United States | Recruiting |
| Medical Research Center /ID# 278680 | Miami, Florida, United States | Recruiting |
| Avanza Medical Research Center /ID# 278885 | Pensacola, Florida, United States | Recruiting |
| NorthShore University-Endeavor Health Evanston Hospital /ID# 277995 | Evanston, Illinois, United States | Recruiting |
| Integrity Clinical Research /ID# 278710 | Wichita, Kansas, United States | Completed |
| Mayo Clinic Hospital Rochester /ID# 278995 | Rochester, Minnesota, United States | Recruiting |
| Novant Health New Hanover Regional Medical Center /ID# 261979 | Wilmington, North Carolina, United States | Recruiting |
| Cleveland Clinic - Cleveland /ID# 277914 | Cleveland, Ohio, United States | Recruiting |
| Prisma Health Greenville Memorial Hospital /ID# 261995 | Greenville, South Carolina, United States | Recruiting |
| Baylor University Medical Center /ID# 261955 | Dallas, Texas, United States | Recruiting |
| Carilion Roanoke Memorial Hospital /ID# 278577 | Roanoke, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07226791